BNP Paribas Arbitrage SA cut its stake in shares of Exponent Inc. (NASDAQ:EXPO) by 51.0% during the third quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 4,007 shares of the company’s stock after selling 4,171 shares during the period. BNP Paribas Arbitrage SA’s holdings in Exponent were worth $205,000 at the end of the most recent quarter.
Several other large investors have also recently bought and sold shares of EXPO. PNC Financial Services Group Inc. boosted its position in Exponent by 1,814.5% in the second quarter. PNC Financial Services Group Inc. now owns 258,417 shares of the company’s stock valued at $15,094,000 after buying an additional 244,919 shares in the last quarter. Henderson Group PLC boosted its position in Exponent by 57.6% in the second quarter. Henderson Group PLC now owns 350,913 shares of the company’s stock valued at $20,497,000 after buying an additional 128,261 shares in the last quarter. Emerald Acquisition Ltd. acquired a new position in Exponent during the second quarter valued at about $4,774,000. Vanguard Group Inc. boosted its position in Exponent by 3.9% in the second quarter. Vanguard Group Inc. now owns 2,004,471 shares of the company’s stock valued at $117,081,000 after buying an additional 75,731 shares in the last quarter. Finally, Riverhead Capital Management LLC boosted its position in Exponent by 1,044.8% in the second quarter. Riverhead Capital Management LLC now owns 66,968 shares of the company’s stock valued at $6,278,000 after buying an additional 61,118 shares in the last quarter. Hedge funds and other institutional investors own 91.46% of the company’s stock.
Exponent Inc. (NASDAQ:EXPO) traded up 0.36% on Wednesday, hitting $50.42. The stock had a trading volume of 12,106 shares. The stock has a market cap of $1.31 billion, a P/E ratio of 28.81 and a beta of 0.85. The company’s 50-day moving average is $50.23 and its 200-day moving average is $51.95. Exponent Inc. has a one year low of $44.82 and a one year high of $59.71.
Exponent (NASDAQ:EXPO) last announced its earnings results on Tuesday, July 19th. The company reported $0.38 EPS for the quarter, missing the consensus estimate of $0.43 by $0.05. The company had revenue of $77.30 million for the quarter, compared to the consensus estimate of $80.46 million. Exponent had a return on equity of 16.02% and a net margin of 15.13%. On average, analysts anticipate that Exponent Inc. will post $1.59 earnings per share for the current fiscal year.
The business also recently announced a quarterly dividend, which was paid on Friday, September 23rd. Investors of record on Friday, September 2nd were issued a dividend of $0.18 per share. This represents a $0.72 annualized dividend and a dividend yield of 1.43%. The ex-dividend date of this dividend was Wednesday, August 31st. Exponent’s payout ratio is 41.62%.
EXPO has been the subject of several analyst reports. Zacks Investment Research cut Exponent from a “hold” rating to a “strong sell” rating in a research report on Friday, July 22nd. Cantor Fitzgerald initiated coverage on Exponent in a research report on Friday, August 26th. They set a “buy” rating and a $57.00 price objective for the company. Finally, Avondale Partners initiated coverage on Exponent in a research report on Thursday, July 7th. They set a “market perform” rating and a $60.00 price objective for the company.
In other Exponent news, CEO Paul R. Johnston sold 5,500 shares of Exponent stock in a transaction dated Thursday, July 14th. The shares were sold at an average price of $59.27, for a total value of $325,985.00. Following the completion of the sale, the chief executive officer now owns 58,958 shares in the company, valued at approximately $3,494,440.66. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Also, CEO Paul R. Johnston sold 5,578 shares of Exponent stock in a transaction dated Friday, July 8th. The stock was sold at an average price of $58.15, for a total transaction of $324,360.70. Following the completion of the sale, the chief executive officer now owns 64,458 shares of the company’s stock, valued at approximately $3,748,232.70. The disclosure for this sale can be found here. Corporate insiders own 3.50% of the company’s stock.
Exponent Company Profile
Exponent, Inc, along with its subsidiaries, is a science and engineering consulting company. The Company operates through two segments: Engineering and Other Scientific, and Environmental and Health. Its Engineering and Other Scientific segment includes biomechanics, biomedical engineering, buildings and structures, civil engineering, construction consulting, electrical engineering and computer science, engineering management consulting, human factors, industrial structures, materials and corrosion engineering, mechanical engineering, polymer science and materials chemistry, technology development, thermal sciences and vehicle analysis services.
Want to see what other hedge funds are holding EXPO? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Exponent Inc. (NASDAQ:EXPO).
Receive News & Ratings for Exponent Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Exponent Inc. and related companies with MarketBeat.com's FREE daily email newsletter.